Open roles at Transperfect
Latest Transperfect Signals
What they do
TransPerfect has acquired Synterex, a Massachusetts-based clinical and regulatory consulting firm, to enhance its medical writing capabilities with AI-assisted technology. The financial terms were not disclosed. This acquisition aims to streamline the development of regulated content for pharmaceutical and biotechnology companies by integrating Synterex's expertise with TransPerfect's global infrastructure.
Why it matters
TransPerfect is integrating Synterex's AgileWriter.ai platform, which automates document management for regulated content, into its existing medical writing services. This technology enhances the authoring, review, and management processes while ensuring compliance and oversight, crucial in the highly regulated life sciences sector.
Traction
TransPerfect operates from over 150 cities worldwide and serves more than 6,000 organizations with its GlobalLink technology for multilingual content management. The acquisition of Synterex is expected to bolster its capabilities in clinical and regulatory writing, targeting pharmaceutical and biotech companies that require rigorous documentation processes.
Where the market is going
This acquisition positions TransPerfect to challenge traditional medical writing firms by leveraging AI to streamline workflows that are typically cumbersome and manual. By combining automation with specialized expertise, TransPerfect is betting on a future where efficiency and compliance coexist, potentially disrupting the status quo in clinical documentation.